graphic
abstract
highlight
solubl
human
inhibit
infect
directli
infect
human
blood
vessel
kidney
organoid
human
organoid
model
system
studi
correspond
alimirazimi
svase
josefpenning
ubcca
jmp
nmontserrat
ibecbarcelonaeu
nm
clinicalgrad
recombin
human
reduc
infect
cell
multipl
human
organoid
model
previous
provid
first
genet
evid
angiotensin
convert
enzym
critic
receptor
sever
acut
respiratori
syndrom
coronaviru
sarscov
protect
lung
injuri
provid
molecular
explan
sever
lung
failur
death
due
sarscov
infect
also
identifi
key
receptor
infect
propos
inhibit
interact
might
use
treat
patient
howev
known
whether
human
recombin
solubl
block
growth
show
clinic
grade
reduc
recoveri
vero
cell
factor
equival
mous
effect
also
show
directli
infect
engin
human
blood
vessel
organoid
human
kidney
organoid
inhibit
data
demonstr
significantli
block
earli
stage
infect
outbreak
emerg
infecti
diseas
continu
challeng
human
health
report
incid
emerg
reemerg
zoonot
diseas
increas
mani
part
world
sever
acut
respiratori
syndrom
coronaviru
sarscov
first
emerg
year
ago
drosten
et
al
decemb
novel
coronaviru
cross
speci
barrier
infect
human
gorbalenya
et
al
effect
transmit
person
person
lead
pneumonia
outbreak
first
report
wuhan
china
guan
et
al
jiang
et
al
zhou
et
al
viru
caus
coronaviru
influenzalik
symptom
rang
mild
diseas
sever
lung
injuri
multiorgan
failur
eventu
lead
death
especi
older
patient
comorbid
declar
public
health
emerg
pandem
proport
http
wwwwhoint
pandem
enorm
burden
public
health
alreadi
markedli
affect
civil
societi
global
economi
share
multipl
similar
sarscov
andersen
et
al
lu
et
al
zhu
et
al
phylogenet
analysi
demonstr
viru
belong
lineag
b
betacoronaviru
genu
chan
et
al
letko
et
al
receptor
bind
domain
rbd
similar
sarscov
rbd
suggest
possibl
common
host
cell
receptor
identifi
function
sarscov
receptor
vitro
group
vivo
kuba
et
al
overexpress
human
enhanc
diseas
sever
mice
infect
sarscov
demonstr
viral
entri
cell
critic
step
yang
et
al
report
inject
sarscov
spike
mice
decreas
express
level
therebi
worsen
lung
injuri
kuba
et
al
thu
serv
entri
receptor
sarscov
protect
lung
injuri
three
recent
cryoelectron
microscopi
cryoem
studi
demonstr
spike
protein
directli
bind
spike
protein
recogn
human
even
higher
bind
affin
spike
sarscov
wall
et
al
wan
et
al
wrapp
et
al
recent
demonstr
cell
cultur
solubl
fuse
ig
wrapp
et
al
nonspecif
proteas
inhibitor
call
camostat
mesyl
hoffmann
et
al
inhibit
infect
pseudoviru
bear
protein
high
dose
mgml
camostat
mesyl
also
shown
partial
reduc
growth
expect
previou
studi
virus
hoffmann
et
al
normal
adult
human
lung
express
primarili
alveolar
epitheli
type
ii
cell
serv
viral
reservoir
cell
produc
surfact
reduc
surfac
tension
thu
prevent
alveoli
collaps
henc
critic
ga
exchang
function
lung
dobb
injuri
cell
could
explain
sever
lung
injuri
observ
patient
other
also
shown
express
multipl
extrapulmonari
tissu
includ
heart
kidney
blood
vessel
intestin
crackow
et
al
danilczyk
penning
ding
et
al
gu
et
al
ham
et
al
zhang
et
al
tissu
distribut
organ
may
explain
multiorgan
dysfunct
observ
patient
guan
et
al
huang
et
al
report
clinicalgrad
human
recombin
solubl
alreadi
test
phase
phase
clinic
trial
haschk
et
al
khan
et
al
reduc
viral
growth
vero
cell
factor
moreov
show
human
blood
vessel
organoid
kidney
organoid
readili
infect
significantli
inhibit
earli
stage
infect
studi
potenti
therapeut
intervent
earli
februari
isol
nasopharyng
sampl
patient
sweden
confirm
success
cultur
vero
cell
isol
viru
sequenc
nextgener
sequenc
genbank
electron
microscopi
show
prototyp
coron
shape
viral
particl
isol
figur
phylogenet
analysi
show
viru
belong
clad
figur
inhibit
infect
dosedepend
manner
alreadi
undergon
clinic
phase
phase
test
khan
et
al
consid
treatment
receptor
want
provid
direct
evid
clinicalgrad
inde
interfer
infect
end
infect
cell
cell
use
isol
differ
number
plaqueform
unit
pfu
moi
pfu
moi
pfu
moi
viral
rna
marker
replic
purifi
cell
assay
qrtpcr
figur
infect
cell
presenc
h
follow
wash
incub
without
significantli
inhibit
infect
h
postinfect
figur
data
demonstr
inhibit
attach
viru
cell
importantli
expect
neutral
agent
inhibit
depend
initi
quantiti
viru
inoculum
dose
figur
establish
dosedepend
contrast
equival
mous
recombin
solubl
produc
way
inhibit
infect
figur
final
perform
experi
cell
infect
presenc
h
captur
newli
produc
viru
particl
h
could
infect
neighbor
cell
observ
significantli
reduc
viru
infect
presenc
figur
figur
note
addit
human
mous
toxic
cell
monitor
h
data
shown
data
show
significantli
reduc
infect
vitro
primari
site
infect
appear
lung
may
sourc
viral
spread
tissu
kidney
intestin
viru
found
stool
young
et
al
urin
ling
et
al
moreov
viremia
establish
cours
diseas
although
viral
rna
blood
infrequ
observ
howev
viru
size
nm
indic
virem
must
first
infect
blood
vessel
prior
local
tissu
infect
test
hypothesi
establish
human
capillari
organoid
induc
pluripot
stem
cell
ipsc
figur
infect
isol
note
organoid
close
resembl
human
capillari
lumen
endotheli
line
pdgfr
pericyt
coverag
well
format
basal
membran
wimmer
et
al
capillari
organoid
analyz
qrtpcr
presenc
viral
rna
day
primari
exposur
importantli
follow
infect
could
detect
viral
rna
blood
vessel
organoid
viral
rna
increas
day
day
postinfect
figur
indic
activ
replic
supernat
infect
organoid
collect
day
postinfect
could
effici
infect
vero
cell
figur
show
infect
capillari
organoid
produc
progeni
viru
importantli
addit
markedli
reduc
infect
engin
human
blood
vessel
figur
note
addit
human
mous
toxic
human
blood
vessel
monitor
day
data
shown
data
show
human
capillari
organoid
infect
infect
significantli
inhibit
other
previous
shown
strongli
express
kidney
tubul
danilczyk
penning
moreov
report
found
urin
ling
et
al
test
whether
directli
infect
human
tubular
kidney
cell
gener
kidney
organoid
human
embryon
stem
cell
suspens
cultur
adapt
protocol
garreta
et
al
importantli
kidney
differenti
organoid
demonstr
promin
tubularlik
structur
detect
lotu
tetraglobu
lectin
ltl
marker
proxim
tubular
epitheli
cell
figur
tubularlik
cell
also
express
solut
carrier
figur
togeth
furthermor
ltlposit
ltl
cell
fraction
organoid
express
marker
proxim
tubular
ident
figur
singlecel
profil
kidney
organoid
show
presenc
cell
express
proxim
tubul
podocyt
ii
cell
cluster
express
key
marker
gene
proxim
tubular
cell
podocyt
podxl
respect
figur
thu
kidney
organoid
contain
cell
cluster
express
similar
fashion
observ
nativ
tissu
infect
kidney
organoid
monitor
day
infect
assay
presenc
viral
rna
use
qrtpcr
progeni
viru
determin
use
reinfect
vero
cell
expect
cell
tissu
express
replic
kidney
organoid
figur
supernat
infect
kidney
organoid
collect
day
postinfect
could
effici
infect
vero
cell
figur
show
engin
kidney
organoid
produc
infecti
progeni
viru
importantli
addit
significantli
reduc
mix
min
ad
cultur
medium
cell
cell
wash
h
postinfect
hpi
incub
fresh
medium
cell
recov
hpi
viral
rna
assay
qrtpcr
data
repres
mean
sd
student
test
p
p
b
murin
recombin
solubl
significantli
affect
infect
cell
highlight
specif
block
entri
mix
min
ad
cultur
medium
vero
cell
cell
wash
hpi
incub
fresh
medium
cell
recov
hpi
viral
rna
assay
qrtpcr
data
repres
mean
sd
c
effect
treatment
progeni
viru
vero
cell
infect
indic
moi
inoculum
remov
cell
recov
hpi
viral
rna
assay
qrtpcr
inhibit
progeni
viru
result
significantli
reduc
viru
infect
data
repres
mean
sd
student
test
p
p
murin
recombin
solubl
significantli
affect
infect
cell
highlight
specif
block
entri
cell
infect
indic
moi
treat
murin
recombin
solubl
cell
harvest
hpi
viral
rna
assay
qrtpcr
infect
human
kidney
organoid
dosedepend
manner
figur
note
addit
human
mous
toxic
kidney
monitor
day
data
shown
data
indic
besid
blood
vessel
engin
human
kidney
organoid
also
infect
infect
inhibit
took
center
stage
outbreak
key
receptor
spike
glycoprotein
demonstr
multipl
structur
biochem
interact
studi
wrapp
et
al
zhou
et
al
moreov
multipl
drug
develop
project
includ
develop
vaccin
focus
spike
interact
initi
identifi
mammalian
realiz
fli
carri
two
ortholog
ace
angiotensinconvert
enzym
first
mutant
mice
demonstr
neg
regul
reninangiotensin
system
ra
genet
control
cardiovascular
function
damag
multipl
organ
lung
liver
kidney
clark
turner
crackow
et
al
catalyt
remov
last
amino
acid
angiotensin
ii
therebi
counterbalanc
ace
ang
ii
action
gener
benefici
downstream
peptid
also
catalyt
act
peptid
apelinapj
system
clark
turner
importantli
report
protect
lung
injuri
base
catalyt
domain
critic
vivo
sarscov
spike
glycoprotein
receptor
kuba
et
al
initi
two
receptor
identifi
sarscov
cell
line
name
li
et
al
lectin
lsign
jeffer
et
al
sever
sar
could
partial
explain
sarscov
spike
protein
bind
molecular
interact
site
interfer
catalyt
activ
li
et
al
lead
endocytosi
viru
loss
establish
viciou
circl
viral
infect
local
loss
lung
injuri
protect
led
initi
drug
develop
programth
develop
solubl
recombin
human
drug
undergon
phase
test
healthi
volunt
phase
test
patient
acut
respiratori
distress
syndrom
ard
treml
et
al
data
show
clinicalgrad
human
moleculebut
mous
solubl
significantli
inhibit
infect
reduc
viral
load
factor
howev
observ
antibodi
neutral
experi
mani
virus
inhibit
complet
although
clearli
dosedepend
may
due
fact
might
coreceptorsauxiliari
protein
even
mechan
virus
enter
cell
initi
propos
sar
jeffer
et
al
qi
et
al
second
receptor
also
suggest
base
clinic
data
sar
transmiss
low
possibl
due
low
level
express
upper
respiratori
tract
bertram
et
al
ham
et
al
transmiss
much
greater
sarscov
suggest
might
use
coreceptor
andor
factor
allow
infect
cell
upper
respiratori
tract
lukassen
et
al
importantli
result
demonstr
significantli
block
infect
provid
rational
solubl
might
protect
lung
injuri
also
block
enter
target
cell
patholog
due
sar
mer
limit
lung
damag
occur
multipl
organ
gu
et
express
variou
tissu
includ
heart
kidney
tubul
lumin
surfac
small
intestin
blood
vessel
crackow
et
al
danilczyk
penning
ding
et
al
gu
et
al
ham
et
al
zhang
et
al
suggest
could
also
infect
tissu
show
blood
vessel
well
kidney
organoid
readili
infect
must
enter
blood
stream
infect
tissu
howev
size
infecti
viral
particl
nm
wrapp
et
al
thu
unless
alreadi
tissu
damag
viru
must
enter
vascular
endotheli
cell
migrat
organ
data
engin
human
capillari
organoid
suggest
could
directli
infect
blood
vessel
cell
infect
blood
vessel
organoid
also
shed
progeni
virus
importantli
markedli
inhibit
infect
vascular
organoid
strongli
express
kidney
tubul
control
local
ra
circuit
clark
turner
hashimoto
et
al
infect
model
therefor
engin
human
kidney
organoid
stem
cell
differenti
contain
tubular
network
garreta
et
al
show
infect
human
kidney
organoid
result
infecti
viral
progeni
inhibit
clinic
found
urin
ling
et
al
mani
patient
present
cardiovascular
renal
dysfunct
yang
et
al
zhang
et
al
zhou
et
al
whether
direct
viral
infect
vasculatur
kidney
directli
contribut
observ
multiorgan
damag
patient
need
establish
given
fact
cardiac
cell
express
high
level
heart
alter
first
phenotyp
observ
mutant
mice
crackow
et
al
import
expand
studi
heart
particular
lung
organoid
better
understand
multiorgan
dysfunct
patient
design
studi
focus
earli
stage
infect
demonstr
block
earli
entri
infect
host
cell
make
predict
respect
effect
later
stage
diseas
process
second
studi
lung
organoid
lung
major
target
organ
final
ra
system
repres
complex
network
pathway
influenc
extern
process
simul
model
system
address
issu
studi
need
illumin
effect
later
stage
infect
vitro
vivo
detail
method
provid
onlin
version
paper
includ
follow
sequenc
nextgener
sequenc
genbank
access
number
electron
microscopi
viral
stock
inactiv
use
glutaraldehyd
cell
atcc
grown
dulbecco
modifi
eagl
medium
dmem
thermofish
supplement
nonessenti
aminoacid
thermofish
hepe
thermofish
fb
c
blood
vessel
organoid
engin
human
ip
cell
immunostain
previous
describ
wimmer
et
al
prepar
solubl
recombin
human
murin
clinicalgrad
solubl
recombin
human
amino
acid
produc
polymun
scientif
contract
manufactur
cho
cell
accord
good
manufactur
practic
guidelin
formul
physiolog
aqueou
solut
equival
domain
murin
similarli
overexpress
cho
cell
serum
free
condit
purifi
sequenti
perform
captur
step
deaesepharos
ammonium
sulfat
precipit
purif
via
hicphenyl
sepharos
column
follow
purif
via
superdex
gel
filtrat
column
puriti
murin
protein
determin
via
hplc
concentr
determin
photometr
measur
human
embryon
stem
cell
grown
vitronectin
coat
plate
life
technolog
incub
edta
merck
c
minut
disaggreg
cellswel
plate
multiwel
plate
coat
ml
ml
vitronectin
incub
supplement
essenti
basal
medium
c
overnight
day
day
cell
treat
subsequ
day
advanc
rpmi
basal
medium
thermofish
supplement
mm
chir
merck
penicillinstreptomycin
glutamax
tm
thermofish
medium
chang
everi
day
day
media
chang
advanc
rpmi
supplement
peprotech
mgml
heparin
merck
activin
vitro
day
cultur
rins
twice
pb
resuspend
advanc
rpmi
supplement
mm
chir
mgml
heparin
cellular
suspens
seed
vshape
multiwel
plate
final
concentr
cellswel
centrifug
rpm
minut
result
spheroid
incub
c
cultur
media
replac
advanc
rpmi
supplement
mgml
heparin
addit
day
media
chang
everi
second
day
day
develop
organoid
incub
presenc
advanc
rpmi
media
everi
second
day
gener
phylogenet
tree
creat
genom
epidemiolog
map
differ
isol
use
nextstrain
tool
http
nextstrainorg
hadfield
et
al
sequenc
differ
isol
obtain
gisaid
http
www
gisaidorg
elb
bucklandmerret
screenshot
use
licens
